Investigation of Spinal Posture and Anthropometric Characteristics of Women with Chronic Constipation

September 30, 2024 updated by: Deniz Çakır, Ondokuz Mayıs University
The aim of this study was to compare the spinal posture and anthropometric characteristics of women with Chronic Constipation (CC) and healthy women.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Samsun, Turkey
        • Abant Izzet Baysal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

women with and without chronic constipation

Description

Inclusion Criteria:

  • Inclusion criteria for women with chronic constipation:

    • Constipation according to Rome IV criteria between the ages of 18-65
    • Volunteer
    • Literacy
  • Inclusion criteria for healthy women:

    • No constipation according to Rome IV criteria between the ages of 18-65
    • Volunteer
    • Literacy

Exclusion Criteria:

  • Cancer, neurological disease, serious or uncontrolled systemic or metabolic disease

    • Being pregnant
    • Having a mental problem that will prevent cooperation
    • Having alarm symptoms over the age of 50
    • Having a diagnosis of secondary constipation
    • Being BMI>35
    • Having megacolon/megarectum and inactive (lazy) bowel syndrome
    • Having had colostomy surgery
    • Having a history of recent abdominal surgery
    • Having an open wound or local tumor in the abdominal region
    • Having an abdominal hernia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control group
The control group consists of healthy women.
After the participants' physical and sociodemographic characteristics were recorded, they were asked to fill out the Constipation Severity Scale and 7- Day Stool Diary to determine their constipation levels. The individuals' anthropometric characteristics were assessed with triceps, subscapula, suprailiac and calf skinfold thickness, humerus and femur epicondyle diameter, biceps and calf circumference measurements, spinal postures were assessed with the Spinal Mouse, and physical activity levels were assessed with the International Physical Activity Questionnaire-Short Form UFAA-KF and pedometer.
CC Group
The CC group consists of women with chronic constipation.
After the participants' physical and sociodemographic characteristics were recorded, they were asked to fill out the Constipation Severity Scale and 7- Day Stool Diary to determine their constipation levels. The individuals' anthropometric characteristics were assessed with triceps, subscapula, suprailiac and calf skinfold thickness, humerus and femur epicondyle diameter, biceps and calf circumference measurements, spinal postures were assessed with the Spinal Mouse, and physical activity levels were assessed with the International Physical Activity Questionnaire-Short Form UFAA-KF and pedometer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anthropometric Characteristics
Time Frame: 1 year

The individuals anthropometric characteristics were assessed with triceps, subscapula, suprailiac and calf skinfold thickness, humerus and femur epicondyle diameter, biceps and calf circumference measurements.

Triceps skinfold thickness, subscapula skinfold thickness, suprailiac skinfold thickness, calf skinfold thickness were measured with skinfold caliper; humeral epicondyle diameter, femoral epicondyle diameter were measured with mechanical caliper, biceps circumference, calf circumference were measured with tape measure. Skinfold thickness measurements were performed by the same person. The measurements were taken from the dominant side of the individuals. The measurements were performed on healthy skin and the areas to be measured were marked with a marker. The individuals were asked to relax their muscles while the measurement was performed. The skin in the marked areas was pulled up by pinching between the index finger and thumb, and the skinfold caliper was placed 1 cm below t

1 year
Spinal Posture
Time Frame: 1 year
The individuals spinal postures were assessed with the Spinal Mouse. Individuals were informed about the device used and the duration of the assessment. Before the measurement, the positions in which the assessment would be made and how to do these positions were explained to the individuals. Then, a trial measurement was made once. The individuals' demographic information was entered into the computer software. Individuals were asked to stand symmetrically with their vertebral columns exposed, to take off their shoes and step onto the mat, and to distribute their weight equally on both feet on a flat surface. Spinal processes starting from C7 to S3 were determined by the physiotherapist and marked with a felt-tip pen. For measurements, the Spinal Mouse device was moved from C7 to the S3 spinous process.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

September 1, 2023

Study Completion (Actual)

October 1, 2023

Study Registration Dates

First Submitted

September 25, 2024

First Submitted That Met QC Criteria

September 30, 2024

First Posted (Actual)

October 1, 2024

Study Record Updates

Last Update Posted (Actual)

October 1, 2024

Last Update Submitted That Met QC Criteria

September 30, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 16/2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Constipation

Clinical Trials on Observation

Subscribe